Skip to main content

Table 3 Tested genes that showed no or very low expression (counts < 100) in MPM patients. FANCD2 showed partially basal expression with a maximum of 214 counts

From: Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

AURKA BRCA1 CHEK2 BRIP1 FANCD2
BARD1 BRCA2 EMSY PALB2 RAD51
\